2013
DOI: 10.1107/s0907444913004459
|View full text |Cite
|
Sign up to set email alerts
|

The structure of an MDM2–Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant

Abstract: The p53-binding site of MDM2 holds great promise as a target for therapeutic intervention in MDM2-amplified p53 wild-type forms of cancer. Despite the extensive validation of this strategy, there are relatively few crystallographically determined co-complex structures for small-molecular inhibitors of the MDM2-p53 interaction available in the PDB. Here, a surface-entropy reduction mutant of the N-terminal domain of MDM2 that has been designed to enhance crystallogenesis is presented. This mutant has been valid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
55
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 62 publications
(59 citation statements)
references
References 49 publications
3
55
0
1
Order By: Relevance
“…The levels of p53 accumulation were also demonstrated by western blotting in NPM1 knockdown and restored cells that were exposed to Act.D and H 2 O 2 . Nutlin-3, an agent that directly disrupts the p53–HDM2 interaction40, was used here as a positive control. Interestingly, Act.D or H 2 O 2 did not produce p53 accumulation in cells bearing C275S NPM1, whereas Nutlin-3 did (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The levels of p53 accumulation were also demonstrated by western blotting in NPM1 knockdown and restored cells that were exposed to Act.D and H 2 O 2 . Nutlin-3, an agent that directly disrupts the p53–HDM2 interaction40, was used here as a positive control. Interestingly, Act.D or H 2 O 2 did not produce p53 accumulation in cells bearing C275S NPM1, whereas Nutlin-3 did (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…(B) Crystal structure of MDM2 in complex with the inhibitor nutlin 3a (PDB entry 4HG7). 378 The orientation is the same as in panel A. The rigid cis -imidazoline scaffold mimics key hydrophobic interactions made by the p53 helix.…”
Section: Figurementioning
confidence: 99%
“…The M06 structure was further compared to the crystal structures of a stapled p53 peptide (SAH-8) bound to Mdm2 (PDB 3V3B) [25] and to Nutlin bound to Mdm2 (PDB 4HGZ) [26] (Figure 4). The M06 stapled peptide forms interactions very similar to those made by the SAH-8 peptide, including the reorientation of the L26 side chain that appears to be associated with increased helicity.…”
Section: Resultsmentioning
confidence: 99%